Showing results (61-70 of 217) with videos related to
Sort By:
Pageof 22
Breast Cancer Research and Treatment|September 16, 2008
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancerAlessandra Gennari, Michele De Tursi, Consiglia Carella, et al.Breast Cancer Research and Treatment|April 3, 2010
Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancerValentina Guarneri, David Miles, Nicholas Robert, et al.Journal of Inorganic Biochemistry|October 11, 2020
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: Design and biological in vitro dataLeonardo Brustolin, Nicolò Pettenuzzo, Chiara Nardon, et al.The American Journal of Case Reports|November 4, 2015
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the LiteratureValentina Polo, Giulia Zago, Stefano Frega, et al.Cancer|September 19, 2002
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimensSergio Ricci, Luca Galli, Aldo Chioni, et al.Clinical Colorectal Cancer|April 16, 2017
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study)Fabio Gelsomino, Federica Bertolini, Gabriele Luppi, et al.Breast Cancer Research and Treatment|December 4, 2010
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studiesHenri Roché, Pierfranco Conte, Edith A Perez, et al.Journal of Clinical Pathology|March 6, 2012
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysisMaria Vittoria Dieci, Elena Barbieri, Stefania Bettelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1Sergio Pecorelli, Giuseppe Favalli, Angiolo Gadducci, et al.The Oncologist|October 7, 2011
Bevacizumab treatment for advanced breast cancerRicardo H Alvarez, Valentina Guarneri, Fikri Icli, et al.Pageof 22